GT Biopharma Inc. (GTBP) Business News Aug. 11, 2025, 11:00 UTC GT Biopharma Advances into Cohort 3 of GTB-3650 Phase 1 Trial Following Safety Review of Cohort 2 Full text
There are no comments here yet...